Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Nature Medicine explores the latest translational and clinical research news, with an immunotherapy that delays the onset of type 1 diabetes in high-risk children and adults.
Nature Medicine explores the latest translational and clinical research news, with news that sotatercept met its primary endpoint in the STELLAR trial.
Nature Medicine explores the latest translational and clinical research news, with an analysis of Intellia and Regeneron’s gene-editing treatment, which reduced levels of transthyretin in patients.
Millions have received the first dose of Sputnik V, but sanctions against its Russian developer may prevent the rollout of second doses, which could leave them under-vaccinated